Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The missing 450 days patients.

<< Previous

Bullboard Posts

Next >>

Comment by Alamir1111on May 02, 2023 11:06am

180 Views

Post# 35425082

RE:The missing 450 days patients.

Good post
Could it be that there is a protocol for practitioners to follow
Example looking at patients med history age etc.and determine the custom treatment required.
Remember a boost in immune system is a blessing for some killer for others

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec